Tandem Therapeutics
Schlieren
About Tandem Therapeutics
Tandem Therapeutics develops peptide therapeutics that target and treat the extracellular matrix barrier.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $159.5K
- Last round: Non-Equity Assistance (Apr 2024)
- Website: tandem-tx.com
Industries & Categories
Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tandem-therapeutics-100224 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.